The subjects were allocated to single-dose groups of 25 , 50 , 100 , 200 or 300 mg ( eight subjects in each dose group , including two placebos ) , or to multiple-dose groups of 100 or 200 mg ( once-daily dosing for 7 days ; nine subjects in each dose group , including three placebos ) .
